Is MYMD or NOBL a better dividend investment in 2026?

MYMD currently yields 110.50% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: MYMD offers higher current income.

What is the dividend yield difference between MYMD and NOBL?

MYMD has a forward dividend yield of 110.50% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 106.50 percentage points.

Home › Compare › MYMD vs NOBL

MYMD vs NOBL: Dividend Comparison 2026

MYMD yields 110.50% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MYMD wins by $5.90M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MYMD

● Live price

110.50%

Share price

$1.81

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.93M

Annual income

$2,132,830.87

Full MYMD calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — MYMD vs NOBL

📍 MYMD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MYMD	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MYMD + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MYMD pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MYMD

Annual income on $10K today (after 15% tax)

$9,392.27/yr

After 10yr DRIP, annual income (after tax)

$1,812,906.24/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, MYMD beats the other by $1,812,141.93/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MYMD + NOBL for your $10,000?

MYMD: 50%NOBL: 50%

100% NOBL50/50100% MYMD

Portfolio after 10yr

$2.98M

Annual income

$1,066,865.04/yr

Blended yield

35.81%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MYMD buys

NOBL buys

No recent congressional trades found for MYMD or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMYMDNOBL

Forward yield	110.50% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$5.93M	$28.0K ✓
Annual income after 10y	$2,132,830.87 ✓	$899.19
Total dividends collected	$5.35M	$6.4K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: MYMD vs NOBL ($10,000, DRIP)

Year	MYMD Portfolio	MYMD Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$21,750	$11,049.72	$11,120	$420.00	+$10.6K → MYMD
2	$45,733	$22,460.60	$12,357	$458.31	+$33.4K → MYMD
3	$93,072	$44,137.91	$13,721	$499.76	+$79.4K → MYMD
4	$183,537	$83,949.70	$15,227	$544.58	+$168.3K → MYMD
5	$351,102	$154,717.47	$16,885	$593.02	+$334.2K → MYMD
6	$652,287	$276,608.54	$18,713	$645.34	+$633.6K → MYMD
7	$1,178,220	$480,272.57	$20,724	$701.81	+$1.16M → MYMD
8	$2,071,454	$810,758.34	$22,938	$762.73	+$2.05M → MYMD
9	$3,548,616	$1,332,160.25	$25,372	$828.41	+$3.52M → MYMD
10	$5,929,850	$2,132,830.87	$28,047	$899.19	+$5.90M → MYMD

MYMD vs NOBL: Complete Analysis 2026

MYMD — Stock

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Full MYMD Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this MYMD vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MYMD vs SCHD MYMD vs JEPI MYMD vs O MYMD vs KO MYMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.